N-staging in Large Cell Neuroendocrine Carcinoma of the Lung: Diagnostic Value of [F]FDG PET/CT Compared to the Histopathology Reference Standard

Overview

Journal EJNMMI Res

Date 2021 Jul 22

PMID 34292419

Citations 2

Authors

Hubertus Hautzel

Yazan Alnajdawi

Wolfgang P Fendler

Christoph Rischpler

Kaid Darwiche

Wilfried E Eberhardt

Lale Umutlu

Dirk Theegarten

Martin Stuschke

Martin Schuler

Clemens Aigner

Ken Herrmann

Till Plones

Affiliations

Soon will be listed here.

Abstract

Background: Large cell neuroendocrine carcinoma of the lung (LCNEC) is a rare entity occurring in less than 4% of all lung cancers. Due to its low differentiation and high glucose transporter 1 (GLUT1) expression, LCNEC demonstrates an increased glucose turnover. Thus, PET/CT with 2-[F]-fluoro-deoxyglucose ([F]FDG) is suitable for LCNEC staging. Surgery with curative intent is the treatment of choice in early stage LCNEC. Prerequisite for this is correct lymph node staging. This study aimed at evaluating the diagnostic performance of [F]FDG PET/CT validated by histopathology following surgical resection or mediastinoscopy. N-staging interrater-reliability was assessed to test for robustness of the [F]FDG PET/CT findings.

Methods: Between 03/2014 and 12/2020, 46 patients with LCNEC were included in this single center retrospective analysis. All underwent [F]FDG PET/CT for pre-operative staging and subsequently either surgery (n = 38) or mediastinoscopy (n = 8). Regarding the lymph node involvement, sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) were calculated for [F]FDG PET/CT using the final histopathological N-staging (pN0 to pN3) as reference.

Results: Per patient 14 ± 7 (range 4-32) lymph nodes were resected and histologically processed. 31/46 patients had no LCNEC spread into the lymph nodes. In 8/46 patients, the final stage was pN1, in 5/46 pN2 and in 2/46 pN3. [F]FDG PET/CT diagnosed lymph node metastasis of LCNEC with a sensitivity of 93%, a specificity of 87%, an accuracy of 89%, a PPV of 78% and a NPV of 96%. In the four false positive cases, the [F]FDG uptake of the lymph nodes was 33 to 67% less in comparison with that of the respective LCNEC primary. Interrater-reliability was high with a strong level of agreement (κ = 0.82).

Conclusions: In LCNEC N-staging with [F]FDG PET/CT demonstrates both high sensitivity and specificity, an excellent NPV but a slightly reduced PPV. Accordingly, preoperative invasive mediastinal staging may be omitted in cases with cN0 disease by [F]FDG PET/CT. In [F]FDG PET/CT cN1-cN3 stages histological confirmation is warranted, particularly in case of only moderate [F]FDG uptake as compared to the LCNEC primary.

Citing Articles

Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial.

Schuler M, Cuppens K, Plones T, Wiesweg M, Du Pont B, Hegedus B Nat Med. 2024; 30(6):1602-1611.

PMID: 38689060 PMC: 11186754. DOI: 10.1038/s41591-024-02965-0.

Large Cell Neuroendocrine Carcinoma of the Lung: Current Understanding and Challenges.

Andrini E, Marchese P, de Biase D, Mosconi C, Siepe G, Panzuto F J Clin Med. 2022; 11(5).

PMID: 35268551 PMC: 8911276. DOI: 10.3390/jcm11051461.

References

Xue J, Zheng J, Guo H, Wang X, Han A . Predictive value of 18-fluorodeoxyglucose positron emission tomography - computed tomography compared to postoperative pathological findings for patients with non-small-cell lung cancer. Mol Clin Oncol. 2014; 3(1):109-114. PMC: 4251154. DOI: 10.3892/mco.2014.408. View

Lo Russo G, Pusceddu S, Proto C, Macerelli M, Signorelli D, Vitali M . Treatment of lung large cell neuroendocrine carcinoma. Tumour Biol. 2016; 37(6):7047-57. DOI: 10.1007/s13277-016-5003-4. View

Darling G . Lymph node assessment in early stage non-small cell lung cancer lymph node dissection or sampling?. Gen Thorac Cardiovasc Surg. 2020; 68(7):716-724. DOI: 10.1007/s11748-020-01345-y. View

Cheng G . Non-Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose. PET Clin. 2017; 13(1):73-81. DOI: 10.1016/j.cpet.2017.09.006. View

Casali C, Cucca M, Rossi G, Barbieri F, Iacuzio L, Bagni B . The variation of prognostic significance of Maximum Standardized Uptake Value of [18F]-fluoro-2-deoxy-glucose positron emission tomography in different histological subtypes and pathological stages of surgically resected Non-Small Cell Lung Carcinoma. Lung Cancer. 2009; 69(2):187-93. DOI: 10.1016/j.lungcan.2009.10.015. View

Agarwal M, Brahmanday G, Bajaj S, Ravikrishnan K, Wong C . Revisiting the prognostic value of preoperative (18)F-fluoro-2-deoxyglucose ( (18)F-FDG) positron emission tomography (PET) in early-stage (I & II) non-small cell lung cancers (NSCLC). Eur J Nucl Med Mol Imaging. 2009; 37(4):691-8. PMC: 2844956. DOI: 10.1007/s00259-009-1291-x. View

Detterbeck F, Boffa D, Tanoue L . The new lung cancer staging system. Chest. 2009; 136(1):260-271. DOI: 10.1378/chest.08-0978. View

Gedik G, Yilmaz F . Is there any improvement in clinical staging with F-FDG PET/CT compared to surgical staging in cases of lung cancer?. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2019; 38(6):348-354. DOI: 10.1016/j.remn.2019.05.005. View

McHugh M . Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012; 22(3):276-82. PMC: 3900052. View

10.

Grondahl V, Binderup T, Langer S, Petersen R, Nielsen K, Kjaer A . Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence. Lung Cancer. 2019; 132:141-149. DOI: 10.1016/j.lungcan.2019.03.013. View

11.

Lapa C, Luckerath K, Rudelius M, Schmid J, Schoene A, Schirbel A . [68Ga]Pentixafor-PET/CT for imaging of chemokine receptor 4 expression in small cell lung cancer--initial experience. Oncotarget. 2016; 7(8):9288-95. PMC: 4891040. DOI: 10.18632/oncotarget.7063. View

12.

Song Y, Lee W, Chung J, Park S, Kim Y, Kim S . Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung. Lung Cancer. 2008; 61(1):54-60. DOI: 10.1016/j.lungcan.2007.11.012. View

13.

Zhang Y, Elam Y, Hall P, Williams H, Pucar D, Patel V . The Role of Fluorodeoxy-D-glucose Positron Emission Tomography/Computed Tomography in Nodal Staging of Nonsmall Cell Lung Cancer in Sequential Surgical Algorithm. World J Nucl Med. 2017; 16(4):281-285. PMC: 5639444. DOI: 10.4103/1450-1147.215486. View

14.

Yamamoto T, Sakairi Y, Nakajima T, Suzuki H, Tagawa T, Iwata T . Comparison between endobronchial ultrasound-guided transbronchial needle aspiration and 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of postoperative nodal recurrence in patients with lung cancer. Eur J Cardiothorac Surg. 2014; 47(2):234-8. DOI: 10.1093/ejcts/ezu214. View

15.

Gu J, Gong D, Wang Y, Chi B, Zhang J, Hu S . The demographic and treatment options for patients with large cell neuroendocrine carcinoma of the lung. Cancer Med. 2019; 8(6):2979-2993. PMC: 6558599. DOI: 10.1002/cam4.2188. View

16.

Lococo F, Cesario A, Paci M, Filice A, Versari A, Rapicetta C . PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. Tumour Biol. 2014; 35(9):8369-77. DOI: 10.1007/s13277-014-2102-y. View

17.

Kwon S, Min J, Song H, Choi C, Na K, Bom H . Impact of Lymphoid Follicles and Histiocytes on the False-Positive FDG Uptake of Lymph Nodes in Non-Small Cell Lung Cancer. Nucl Med Mol Imaging. 2014; 45(3):185-91. PMC: 4043005. DOI: 10.1007/s13139-011-0085-9. View

18.

Bustos Garcia de Castro A, Ferreiros Dominguez J, Delgado Bolton R, Fernandez Perez C, Cabeza Martinez B, Garcia Garcia-Esquinas M . PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings. Radiologia. 2017; 59(2):147-158. DOI: 10.1016/j.rx.2016.12.001. View

19.

Lee A, Choi S, Jung K, Park J, Lee S, Bae S . Characteristics of Metastatic Mediastinal Lymph Nodes of Non-Small Cell Lung Cancer on Preoperative F-18 FDG PET/CT. Nucl Med Mol Imaging. 2014; 48(1):41-6. PMC: 4035153. DOI: 10.1007/s13139-013-0244-2. View

20.

Lee K, Lee Y, Oh S, Jin K, Goo J . Large cell neuroendocrine carcinoma of the lung: CT and FDG PET findings. Eur J Radiol. 2015; 84(11):2332-8. DOI: 10.1016/j.ejrad.2015.07.033. View